Qarziba contains Dinutuximab Beta, 20mg/4.5ml, supplied as injection. Manufacturer: Recordati Rare Diseases. Therapeutic class: Rare Disease – Neuroblastoma.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.